Celldex Therapeutics, Inc. Brain Cancer Vaccine Doubles Survival in Midstage Trial at Duke University and University of Texas MD Anderson Cancer Center
Reuters -- Patients with the brain cancer glioblastoma treated with a vaccine lived nearly twice as long as those who received radiation and chemotherapy, an encouraging result for a cancer that often kills patients within a year, U.S. researchers said on Monday.